Inicio › Cáncer de riñón (carcinoma de células renales) › Misuri › St. Louis
Ensayos clínicos de Cáncer de riñón (carcinoma de células renales) en St. Louis, MO
23 estudios para Cáncer de riñón (carcinoma de células renales) buscan participantes en centros de St. Louis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Washington University Medicine, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
ReclutandoFase 1
- Washington University School of Medicine, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- y 4 más
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
ReclutandoFase 1/2
- Washington University in St. Louis, St Louis
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- y 5 más
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
ReclutandoFase 1/2
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Washington University, St Louis
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
ReclutandoFase 3
- Washington University School of Medicine ( Site 0114), St Louis
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
ReclutandoFase 1/2
- Washington University School of Medicine, St Louis
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
ReclutandoFase 2
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutandoFase 1/2
- Washington University, St Louis
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
ReclutandoFase 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · A 16 mi de distancia
- y 1 más
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ReclutandoFase 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- y 5 más
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
ReclutandoFase 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- y 6 más
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site, St Louis
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
ReclutandoFase 1
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
ReclutandoFase 1
- Washington University School of Medicine, St Louis
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
ReclutandoFase 3
- Missouri Baptist Medical Center, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ReclutandoFase 1
- Washington University School of Medicine, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
ReclutandoFase 2
- Siteman Cancer Center, Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ReclutandoFase 1
- Washington University Medical Campus, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Washington University, St Louis
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
ReclutandoFase 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- y 4 más
Ensayos de Cáncer de riñón (carcinoma de células renales) en otras ciudades
- Houston, TX35 estudios
- New York City, NY27 estudios
- Dallas, TX23 estudios
- Nashville, TN23 estudios
- Los Angeles, CA20 estudios
- Boston, MA16 estudios
- Baldwin Park, CA16 estudios
- Pittsburgh, PA15 estudios
- Philadelphia, PA15 estudios
- Queens, NY15 estudios
- Rochester, MN14 estudios
- Cleveland, OH14 estudios
Otros estudios en St. Louis
- Cáncer de pulmón de células no pequeñas73 estudios
- Cáncer de seno64 estudios
- Cáncer metastásico54 estudios
- Cáncer del colon y del recto50 estudios
- Cáncer (todos los tipos)46 estudios
- Cáncer de próstata46 estudios
- Cáncer de pulmón39 estudios
- Cáncer de ovario38 estudios
- Cáncer de páncreas33 estudios
- Cáncer de endometrio29 estudios
- Carcinoma de células escamosas de cabeza y cuello28 estudios
- Fallo cardíaco26 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.